In a recent study, researchers found that an AI tool created by Jvion was able to predict patients with a high risk of dying in the next 30 days with more accuracy than those predicted to be at low-risk. 

The Jvion CORE™ AI tool is already in use at practices in the US, including at Northwest Medical Specialties, where clinicians say it has helped double palliative care referrals, and led to more meaningful end-of-life conversations with patients who are terminally ill.  Dr John Frownfelter, Chief Medical Officer at Jvion and co-author of the study tells us more.